In this exclusive MedPage Today video, Jonathan Bernstein, MD, of the University of Cincinnati College of Medicine, discusses emerging data on barzolvolimab, an investigational humanized monoclonal ...

If you're being treated for hives, your physician will want to hear what you think about your treatment. Is it working? Are your symptoms improving, staying the same, or getting worse? You may be ...

A panel of experts discuss the clinical trials of dupilumab, the resultant data, and the response of the FDA when approval was requested. Dupilumab has been evaluated in phase 3 clinical trials in ...

If you've ever had an allergic reaction that includes hives-a rash with itchy, raised bumps or welts-then you know how uncomfortable they are. In addition to the intense, sometimes uncontrollable ...

In patients with chronic spontaneous urticaria (CSU) unresponsive to H1-antihistamines, re-treatment with ligelizumab was effective and mostly well tolerated, with both 72-mg and 120-mg doses yielding ...

Please provide your email address to receive an email when new articles are posted on . Urticaria patients taking Dupixent experienced an 8.64-point reduction in itch and 15.86-point reduction in ...

This informational guide, part of PS's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to help.

Panelists discuss how 30%-50% of patients with chronic spontaneous urticaria remain symptomatic despite treatment, examining the impact of treatment burdens, the limitations of targeting the IgE ...

A combination of medications and lifestyle adjustments can help you manage chronic hives and ease your symptoms.

Pimples or a pimple-like rash can develop on any part of the body, including on the legs and thighs. Potential causes include folliculitis, keratosis pilaris, and hives. Pimples often appear as one or ...